The disclosure relates generally to bacterial strains of the genus Anaerostipes, e.g., Anaerostipes rhamnosivorans bacterial strains, and compositions, e.g., pharmaceutical compositions, comprising such bacterial strains. The disclosure further relates to method of using such bacterial strains and compositions for preventing or treating a disorder, e.g., an inflammatory disorder, a gastrointestinal disorder, a metabolic disorder, and/or dysbiosis when administered to a subject in need thereof.

The disclosure relates generally to bacterial strains of the genus Anaerostipes, e.g., Anaerostipes rhamnosivorans bacterial strains, and compositions, e.g., pharmaceutical compositions, comprising such bacterial strains. The disclosure further relates to method of using such bacterial strains and compositions for preventing or treating a disorder, e.g., an inflammatory disorder, a gastrointestinal disorder, a metabolic disorder, and/or dysbiosis when administered to a subject in need thereof.

The present disclosure relates to microcapsules, methods of using such microcapsules in the delivery of drugs and probiotic microbes to subjects in need thereof, and methods of using such microcapsules for in vitro culture of microbes. In particular, the microcapsules comprise novel siloxane-based membranes that maintains transport properties essential to communication and growth of microbes.

The present disclosure relates to microcapsules, methods of using such microcapsules in the delivery of drugs and probiotic microbes to subjects in need thereof, and methods of using such microcapsules for in vitro culture of microbes. In particular, the microcapsules comprise novel siloxane-based membranes that maintains transport properties essential to communication and growth of microbes.

A method of fixating and stabilizing nitric oxide metabolites within fermented natural substance according to an embodiment of the present disclosure includes adding a fermentative strain to nitrogen-containing natural substance and carrying out fermentation. The fermentation efficiency is maximized by optimizing the fermentation conditions so that the productivity of nitric oxide metabolites is significantly improved. Thus, eating a fermented natural substance in which nitric oxide metabolites are fixated and stabilized by the method of the present invention would be helpful for maintaining the homeostasis of human body, in which nitric oxide synthase is either absent or insufficient, based on vasodilation and activation of a neurotransmitter and immune function as medical efficacy of nitric oxide.

A method of fixating and stabilizing nitric oxide metabolites within fermented natural substance according to an embodiment of the present disclosure includes adding a fermentative strain to nitrogen-containing natural substance and carrying out fermentation. The fermentation efficiency is maximized by optimizing the fermentation conditions so that the productivity of nitric oxide metabolites is significantly improved. Thus, eating a fermented natural substance in which nitric oxide metabolites are fixated and stabilized by the method of the present invention would be helpful for maintaining the homeostasis of human body, in which nitric oxide synthase is either absent or insufficient, based on vasodilation and activation of a neurotransmitter and immune function as medical efficacy of nitric oxide.

The disclosure provides novel microbial strains, such as Veillonella sp. strains, and compositions comprising the strains that are capable of converting lactate to propionate and acetate. The disclosure also provides compositions comprising the Veillonella sp. strains and lactate producing bacteria, such as Lactobacillus sp. strains and Bifidobacterium sp. strains. The disclosure further provides methods of improving athletic performance, enhancing exercise endurance and reducing inflammation in a subject upon administration of the disclosed strains or compositions.

The disclosure provides novel microbial strains, such as Veillonella sp. strains, and compositions comprising the strains that are capable of converting lactate to propionate and acetate. The disclosure also provides compositions comprising the Veillonella sp. strains and lactate producing bacteria, such as Lactobacillus sp. strains and Bifidobacterium sp. strains. The disclosure further provides methods of improving athletic performance, enhancing exercise endurance and reducing inflammation in a subject upon administration of the disclosed strains or compositions.

The present disclosure belongs to the technical field of biomedicine, and provides use of Faecalibacterium prausnitzii in preparation of a medicine for treating pathological ventricular remodeling and/or heart failure following myocardial infarction. The Faecalibacterium prausnitzii can improve pathological ventricular remodeling and/or heart failure caused by myocardial infarction in experimental animals, resume the systolic function, reduce the cardiac fibrosis, and inhibit the pathological myocardial hypertrophy of mice with myocardial infarction. Furthermore, the inactivated Faecalibacterium prausnitzii has no such improvement effect.

A method and system for the treatment of honey bees (Apis mellifera), bats, and butterflies protects them from various life threatening conditions, including Colony Collapse Disorder and in particular, provides honey bees with the ability to assimilate and degrade pesticides such as neonicotinoids and fipronil.